Advertise   Subscribe Contact Yemen Post
About Us   Our Mission Terms & Services
Yemen Post Newspaper Logo  
Editor Picture The first of a hundred steps is now complete. We salute those who helped the NDC become the road map for the future Yemen. Strides of success were made, but the real test awaits us all. Will the government deliver and turn ink on paper into reality?  
Hakim Almasmari  
 Publisher & Editor in Chief   
  Email the Editor
Advanced Search
order abortion pill online online pill for abortion online
LATEST UPDATES We apologize for technical issues Yemen Post website is facing :: Friends of Yemen Conference, Yemen’s new plan is a go :: UAE lauds Yemen efforts in safeguarding its diplomats :: Yemen has become a magnet for Islamic militants
order abortion pill online online pill for abortion online
:: US military personnel help Yemen sift through rubbles :: Towards an Arab NATO :: Towards an Arab NATO :: Al Qaeda retaliates against military in Hadhramawt :: The human cost of Yemen’s air strikes :: Compensating Yemen’s drone victims ::
Last updated: 11:16:45 PM GMT(+03) Sunday, 16, December, 2012

Doing good business for better health in Yemen

 Yemen Post Staff
order abortion pill online i need to buy the abortion pill pill for abortion online

By Omar Mulhi

Country Manager for GlaxoSmithKline- Yemen



The drive to ensure access to medicine across Yemen is a vital priority in which private sector companies, governments, NGOs, international agencies and academic institutions all have a vital role to play. True, pharmaceutical companies have not always been seen as altruistic leaders in this field, but in recent years our industry has been playing an increasingly progressive part. Today, we are seen as part of the solution.
Last week, the annual Access to Medicine Index was published. This ranking, published by the Access to Medicine Foundation, an independent, not-for-profit organisation, rates pharmaceutical companies according to their efforts to bring essential medicines to people in low-income countries.
I am pleased that, for the third consecutive time, GlaxoSmithKline (GSK) is ranked highest. This ranking is a public recognition that validates our objective: to improve people’s health and well-being, regardless of where they live in the world or their ability to pay. In developing countries, we give equal focus to building a sustainable business and on working with partners to improve healthcare in that country.
Previously the healthcare industry reached only the more affluent end of the population, but thanks to economic growth and partnerships in these countries, it has led to improvements in the healthcare infrastructure, training and supply, which means we are now able to expand our reach. Further investments and partnerships are required to ensure life-saving medicines reach societies in need, but it is entirely possible for private companies with a social conscience to achieve commercial success and meet the healthcare needs of the people.
GSK’s number-one ranking in the Index further acknowledges our four -part strategic approach in low-income countries, that is:
1) Having a unique business model, that incentivises managers on volume targets to drive access rather than just profit;
2) That caps the price of our patented medicines at no more than 25 per cent of the price in the UK;
3) That re-invests 20 per cent of all profits back into improving Yemen’s healthcare infrastructure; and
4) Is done so in partnership with governments, NGOs and the private sector.
GSK’s business model focuses on selling a higher volume of medicines at lower prices. This allows us to reach more people, and save more lives. This is not easy work, but it is critically important to building a stronger, healthier future for everyone in Yemen.
We are committed to re-investing 20 per cent of profits generated in the world’s least developed countries back into community programmes. These projects are designed to strengthen the local healthcare infrastructure, and provide training for community health workers. Today, we have begun projects in all least developed countries where we make a profit, including Yemen.
GSK is taking a different approach to meeting the challenges in these countries, working in partnership with others and aligning the healthcare needs of people in developing countries with the commercial success that will ensure sustained investment. Our partnerships are central to the success of these endeavours – a sign of the new paradigm for our industry. With the right commitment and support from governments and NGOs and the involvement of the private sector, the potential impact is staggering – to make quality medicines and vaccines available to everyone and not just the privileged few. This will achieve quantum gains in Yemen’s health and development to provide a better, healthier and brighter future for people, communities and societies. That, surely, is a goal worth pursuing.

About the author
Omar Mulhi worked with GSK between 1995 and 2010. He started his career as a medical representative and was promoted to a number of progressively senior positions in the organisation with the last role being Second Line Sales Manager in 2010. Omar took the role of GSK country manager effective from June 2012 looking after both institutional and
private business in Yemen.





where can i buy abortion pills abortion pill abortion pills



    - Ads- مادة إعلانية
  BY: Shaher Abdulhak Saleh
مبادرة: معا لتأييد ونشر الخير في اليمن
لنشر حملاتكم التي تبث في مصلحة الخير لليمن يرجى التواصل مع
شاهر عبدالحق صالح على العنوان التالي
Initiative: together to support and spread the good in Yemen
To publish your campaigns, which broadcasts in the interest of the good of Yemen please communicate with Shaher Abdulhak Saleh at the following address:



Source: Yemen Post Newspaper
KSA to help Yemen defeat Malaria to protect its people
MERS-related death prompt fears of outbreak in Yemen
where can i buy abortion pills open abortion pills
Yemen health officials move to fight Schistosomiasis
Self sustaining cardiac surgery program established in USTH
Social Health Insurance in Yemen: The Unpaved Road
Female empowerment through voluntary work in the health sector!
Yemen AIDS program to tackle stigmatization
More Support to Yemeni Patients and Health Sector; GSK Launches Access to Medicine Program
Cases of AIDS in Yemen on the rise
Yemen battles schistosomiasis: national health campaign
Leave a Comment
Comment will be published once it has been approved by our moderators.

Yemen Post may edit comments for length and clarity but will not change the tone of the message. Comments will only be accepted if all fields (including name) are filled correctly and the message isn't abusive, defamatory or offensive. All comments sent may be forwarded for use in the Yemen Post newspaper.
Article Tools
Email this Article Email this article
Print Friendly Version Print
Email this Article Email the Editor
Most popular
 We apologize for technical issues Yemen Post website is facing
 Corruption is holding Yemen back
 Friends of Yemen Conference, Yemen’s new plan is a go
 UAE lauds Yemen efforts in safeguarding its diplomats
 Towards an Arab NATO
 Friends of Yemen Conference kicks off in London
  Letters to the Editor
  Dear President
  Submit Your Articles
order abortion pill online online pill for abortion online
abortion pill prescription abortion pill abortion pills
where can i buy abortion pills abortion pill abortion pills
  Readers' Letters

abortion pill prescription abortion pill abortion pills
Quick poll
Do you think President Hadi is building the base to rule Yemen for many years?
abortion pill prescription abortion pill buy online abortion pills


© Yemen Post. All Rights Reserved 2007- 2014    

 Designed and developed by